Wrath of the Righteous and Warhammer 40,000: Rogue Trader — together with Alcon Interactive Group revealed a selection of new ...

Alcon showcases new data at APACRS 2025, emphasizing advancements in IOL technology and surgical precision for improved ...

Tom McDonald worked at Alcon for nearly four decades and writes about the eyecare giant's remarkable growth that started in ...

ALC's Q2 earnings top estimates but revenues fall short, sending shares down more than 10% as margins tightened and 2025 sales outlook narrowed.

Morgan Stanley analyst Patrick Wood lowered the firm’s price target on Alcon (ALC) to $80 from $84 and keeps an Equal Weight rating on the shares after updating the firm’s model for Q2 earnings that ...

Shares of Alcon Inc. snapped a six-day winning streak on Wednesday, losing 10.07 percent to close at $81.04 apiece as investor sentiment was dampened by a dismal earnings performance and a weaker ...

Alcon (NYSE:ALC) stock continues to decline as J.P. Morgan downgrades the company following mixed Q2 2025 results and lowered sales guidance. Read more here.

Alcon affirmed fiscal year 2025 adjusted earnings of $3.05-$3.15 versus consensus of $3.12. The company lowered 2025 sales guidance from $10.4 billion-$10.5 billion to $10.3 billion-$10.4 billion, ...

The latest health news covers underwhelming results from Viking's weight-loss pill, potential tax exemptions on health insurance in India, Brazil's declining chicken exports due to bird flu, U.S.

Swiss-American eye care firm Alcon Inc (NYSE:ALC) stock slumped on Wednesday after the company cut its 2025 outlook late on ...

Shares of Alcon fell after the company posted a lower second-quarter profit and cut its full-year sales outlook, saying it expected a full-year tariff impact of $100 million. The stock was down 9.1% ...